SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending amidst community discussion about a recent dip attributed to a report of security flaws in its software, which some investors believe is a buying opportunity due to the company's rebuttal and potential for a Monday recovery. The community is debating whether the dip is a result of a coordinated short attack or an overreaction, with many expressing confidence in Palantir's long-term prospects within the growing AI sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to community excitement around its potential connection to rare earth mineral deals with the Trump administration, reminiscent of similar situations with LAC.  The community is actively speculating on upcoming news and the stock's potential, drawing parallels to other rare earth mineral stocks that have surged following government interest. Some investors are also pointing out the valuation discrepancy between CRML and EULIF.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN is gaining attention, with community members highlighting its website and Dexscreener link. Advocates express optimism, noting consistent growth, solid volume, and strong community support, while drawing parallels to the broader cultural significance of cannabis. The coin is promoted with the slogan "Like Bitcoin But Way Higher".

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending amid speculation of a potential government stake in the company, similar to previous investments in the rare earth sector. Community chatter revolves around the possibility of a Trump administration deal and its potential impact on the stock price, with comparisons being drawn to MP Materials' government-backed surge. Despite some concerns about potential dilution, the focus remains on the company's strategic positioning in the rare earth magnet supply chain and its importance to national security.

The project is a groundbreaking memecoin powered by advanced AI that interacts with the community across platforms like X (formerly Twitter). The AI generates unique content, including text, images, videos, music, and animations, all based on current trends. As it learns from user interactions, the AI becomes more responsive, providing engaging and dynamic experiences. Holders are rewarded with exclusive content, voting rights, and governance opportunities, creating an interactive ecosystem that evolves with the community.

Shadow AI

Shadow AI ($SHADOAI) is trending as the community expresses bullish sentiment and anticipates a potential breakout. Discussions highlight its connection to the Solana blockchain and other popular tokens like PEPE and SHIB. The community frames Shadow AI as a hidden gem with significant upside potential in the AI crypto space.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai ($AI) is trending amid discussion of buyout rumors, potential M&A targets, and analyst opinions, with some traders citing a Wedbush analyst naming it a takeover target and Reddit threads fueling speculation. Despite its association with the AI sector, some community members are questioning its growth strategy and comparing it to competitors. Others express optimism based on its ticker symbol and potential for government contracts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as excitement builds around quantum computing's potential, fueled by contract wins and overall sector momentum. Community members are actively discussing potential catalysts, including government contracts and big tech partnerships, with some comparing QBTS to NVDA in its early stages. Despite some skepticism regarding valuation, the stock is experiencing increased attention and trading volume.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending amidst discussions about potential market manipulation and price targets, with the community debating its true valuation and reacting to volatile price swings. Some traders are taking advantage of the dips while others express frustration over missed profit opportunities, remaining optimistic about long-term growth in the telehealth sector. Recent news and developments may have contributed to the stock's activity.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending as investor interest surges, fueled by bullish analyst coverage and eased risk aversion in the market. The community is actively discussing the company's potential shift towards crypto/blockchain applications and a recent price target upgrade. Some traders are eyeing potential short squeezes, while others remain skeptical about the company's revenue and valuation compared to peers like $IONQ and $QBTS.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as investors discuss the stock's persistent downtrend despite positive fundamentals, including profitability and revenue growth; the community is debating potential catalysts, such as a buyout or strategic acquisition, while expressing frustration with management's actions and overall market manipulation impacting the stock's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gain Therapeutics' GT-02287 study to deliver positive findings, says Roth MKM

Gain Therapeutics' GT-02287 study to deliver positive findings, says Roth MKM...

Optimistic Outlook for Gain Therapeutics Amid Progress of GT-02287 and Successful Financing

Maxim Group analyst Jason McCarthy has maintained their bullish stance on GANX stock, giving a Buy rating today. Jason McCarthy's rating is based o...

Gain Therapeutics Advances Parkinson's Treatment in Phase 1

The latest update is out from Gain Therapeutics (GANX). Gain Therapeutics, Inc. has successfully completed the multiple ascending dose phase of its...

Gain Therapeutics, Inc. (NASDAQ:GANX) Director Jeffrey Scott Riley Acquires 30,000 Shares

Gain Therapeutics, Inc. (NASDAQ:GANX - Get Free Report) Director Jeffrey Scott Riley bought 30,000 shares of the business's stock in a transaction on Thursday, March 28th. The shares were acquired at...

Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Update

Gain Therapeutics, Inc. (NASDAQ:GANX - Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 156,700 shares, an...

Director Jeffrey Riley Acquires 30,000 Shares of Gain Therapeutics Inc (GANX)

Gain Therapeutics appoints Jonas Hannestad as CMO

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

BETHESDA, Md., April 01, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ( Gain , or the Company ), a clinical-stage biotechnology company leading the discovery and development of...

Buy Rating Affirmed for Gain Therapeutics on Promising Parkinson's Treatment and Solid Financial Outlook

Gain Therapeutics (GANX Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from...

Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update

BETHESDA, Md., March 26, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ( Gain , or the Company ), a clinical-stage biotechnology company leading the discovery and development of...

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.

Gain Therapeutics Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

GANX
Gain Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GANX News

GANX Gain Therapeutics Inc